Pure Global
NCT05894863

Smart Flex Stent System for the Treatment Long Femoropopliteal Artery Lesions

Smart Flex Stent System for the Treatment Long Femoropopliteal Artery Lesions: the SAFARI Study
RenJi Hospital·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Peripheral Arterial Disease
Drug/Device/Intervention
Smart flex stent
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
RenJi Hospital
Location
Shanghai, China
Timeline & enrollment
Phase
N/A
Start date
May 31, 2023
End date
Jan 02, 2027
Enrollment
120 participants
Primary outcome

Primary patency,Freedom of major adverse events (MAEs)

Summary

This study aims to evaluate the effectiveness and safety of the Smart flex stent system in
 treating long femoropopliteal native lesions.

ICD-10 classifications
Peripheral vascular disease, unspecifiedOther peripheral vascular diseasesOther specified peripheral vascular diseasesPeripheral angiopathy in diseases classified elsewhereOther congenital malformations of peripheral vascular system
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05894863
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05894863 through Pure Global AI's free database. This phase not specified trial is sponsored by RenJi Hospital and is currently Recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.